Short answer
Krystal Biotech, Inc. (KRYS) filed an 8-K current report with the SEC on May 20, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders elected Krish S. Krishnan and Christopher Mason as Class III directors for three-year terms.
Krystal Biotech, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders elected Krish S. Krishnan and Christopher Mason as Class III directors for three-year terms
- KPMG LLP ratified as independent auditor for fiscal year ending December 31, 2026, with 28,443,155 votes for
- Executive compensation approved on an advisory basis, with 25,679,318 votes for versus 1,195,788 against
- Unaffiliated stockholders approved the Non-Employee Director Compensation Policy, with 21,374,021 votes for
- Krish S. Krishnan signed the filing as chairman and chief executive officer dated May 19, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Krystal Biotech, Inc. 8-K filings
Get the next KRYS 8-K as it lands
Follow KRYS for push alerts, or ask the research agent what this filing means.